$51.090
-1.354 (-2.65%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DRUG Prediction & Forecast by Similar Chart Analysis
Alphio's DRUG stock price prediction model matches the current Bright Minds Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $54.31 (+0.53%). The 1-week path is $53.70 (-0.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bright Minds Biosciences Inc Stock?
Bright Minds Biosciences Inc is a good buy right now. The current price is $52.48, and analysts have set a price target as high as $220, indicating significant upside potential. Additionally, the company has ramped up its R&D spending to C$18.7 million, a substantial increase from C$3.6 million a year earlier, which shows commitment to advancing its drug development pipeline. However, the company has reported negative earnings per share (EPS) of -1.09 in Q2 2026, which is a risk to consider.
DRUG stock price ended at $51.09 on Monday, after losing -2.65%
Bright Minds Biosciences Inc (DRUG) last closed at $54.0200005, gaining +5.73%. These facts feed the 1-day and 1-week DRUG price prediction above.
Forecast Drivers
Bright Minds Biosciences Inc (DRUG) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches DRUG, ranked by similarity.
Seasonality analysis for DRUG
Historically the probability of a positive October return for DRUG is 56.92%. November offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DRUG
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $28.65 | $31.00 | $35.50 | -42.61% |
| Nov 2026 | $24.76 | $28.06 | $30.05 | -48.05% |
| Dec 2026 | $25.45 | $27.20 | $27.32 | -49.66% |
In 2026, Bright Minds Biosciences Inc (DRUG) is projected to range from $24.76 to $35.50.
Bright Minds Biosciences Inc 2026 monthly forecast
In Oct 2026, Bright Minds Biosciences Inc is projected to average $31.00, with a low of $28.65 and high of $35.50.
In Nov 2026, Bright Minds Biosciences Inc is projected to average $28.06, with a low of $24.76 and high of $30.05.
In Dec 2026, Bright Minds Biosciences Inc is projected to average $27.20, with a low of $25.45 and high of $27.32.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.